Learn more

GREEN CROSS CORP

Overview
  • Total Patents
    2,399
  • GoodIP Patent Rank
    8,138
  • Filing trend
    ⇧ 83.0%
About

GREEN CROSS CORP has a total of 2,399 patent applications. It increased the IP activity by 83.0%. Its first patent ever was published in 1962. It filed its patents most often in Japan, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are AVIXGEN INC, SLOAN KETTERING INST CANCER and THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES.

Patent filings per year

Chart showing GREEN CROSS CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yokoyama Kazumasa 397
#2 Suyama Tadakazu 307
#3 Kamimura Yatsuhiro 154
#4 Takechi Kazuo 110
#5 Nishida Masayuki 104
#6 Funakoshi Satoru 102
#7 Arimura Hirobumi 96
#8 Fukaya Tsutomu 88
#9 Funakoshi Satoshi 85
#10 Fukaya Chikara 84

Latest patents

Publication Filing date Title
WO2020251187A1 Antibody to tigit and use thereof
JP2020125350A Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor
WO2020204305A1 Fusion protein comprising anti-mesothelin antibody, anti-cd3 antibody or anti-egfr antibody, bispecific or trispecific antibody comprising same, and uses thereof
KR20200118562A Bispecific antibody that specifically binds to gpnmb and cd3 and use thereof
KR102084912B1 Conformational epitope of hepatitis b virus surface antigen and antibody specifically binding to the same
KR20200034321A Highly efficient anti-TFPI antibody composition
BR112020006311A2 METHOD FOR PREPARING A KNOCKOUT RABBIT OF FACTOR VIII OR FACTOR IX GENE AND USE OF THE SAME
KR20190136271A Method and composition for treating hunter syndrome by administration of lateral ventricle of cerebrum
KR20190112982A Method for obtaining bordetella pertussis related proteins comprising affinity chromatography
KR20180026688A Composition comprising long-acting Erythropoietin
KR20190063765A Anti-ceacam1 antibody and use thereof
KR20190047376A Improved Method for Purification of Immunoglobulin
KR101973060B1 Antibody against cd3 and pharmaceutical composition for treating cancer comprising the same
KR101966362B1 Antibody against msln and pharmaceutical composition for treating cancer comprising the same
WO2019045149A1 Method for purifying a sulfatase protein
KR20170098206A Pharmaceutical formulation comprising anti-egfr antibody
KR20190013296A Method for obtaining bordetella pertussis related protein comprising processes of freezing and thawing
KR20180108183A Anti-ceacam1 antibody and use thereof
WO2017116066A1 Methods and compositions for treating hunter syndrome
KR20180056028A Methods for Eliminating Factor XI during Plasma Protein Purification